<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00460291</url>
  </required_header>
  <id_info>
    <org_study_id>ProVena</org_study_id>
    <nct_id>NCT00460291</nct_id>
  </id_info>
  <brief_title>Pilot Study to Asses the Function and Patency of Polyester-Coated Composite Bypasses From Autologous Varicose Veins</brief_title>
  <acronym>PROVENA</acronym>
  <official_title>Pilot Study to Asses the Function and Patency of Polyester-Coated Composite Bypasses From Autologous Varicose Veins</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Johann Wolfgang Goethe University Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>B. Braun Melsungen AG</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>Johann Wolfgang Goethe University Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      If patients need to undergo bypass surgery, either an autologous vein can be used as bypass
      or, if there are no suitable veins are available, a prosthetic graft can be implanted.
      Varicose veins normally are judged not to be suitable as bypass. The ProVena vein support,
      made from polyester, is considered to strengthen varicose veins so that they they become
      suitable as bypass. Thereby, the advantages of an autologous bypass and the stability of
      polyester material can be combined.

      Patients that take part in the trial recieve an autologus bypass with a varicose vein, coated
      with ProVena. They are followed up at 3 and 6 months after implantation of a ProVena-coated
      bypass via duplex-sonography to assess the graft patency.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The ProVena trial is a non-randomised multi-centre trial, aiming to assess the suitability of
      the ProVena vein support.

      Currently, autologous veins are preferred to prosthetic grafts (Klinkert et al. 2004), but
      they are not considered to be suitable if they are varicose.

      Some early data indicate that these veins can be used if an external support is applied
      (Moritz et al. 1993, 1992, Neufang et al. 2003). The proVena vein graft has been tested in
      animal experiments. All bypasses showed a reduced intima hyperplasia, no disadvantages were
      found. Nevertheless, as a ProVena-coated bypass cannot be regarded as completely autologus,
      it is necessary whether the coating does not increase the risk of

        -  infections

        -  scar formation, reducing the patency

        -  higher incidence of seroma

      ProVena is made from polyester filaments, similar to the material used for prosthetic grafts.
      As the material is used since years in peripheral bypass surgery, we do not expect increased
      risks.

      It is planned to include 50 Patients in 10 centres. Patients can be included if they match
      the eligibility criteria, need to undergo peripheral bypass surgery and have varicose veins
      normally not suitable to form a bypass graft. If patients agree to take part and give
      informed consent, baseline data are collected and the surgery is protocolled. Patients are
      followed up after 3 ands six months by duplex sonography. The inflammation parameters are
      detected via analysis of a blood sample. Main endpoints and secondary endpoints are as
      follows:

      Main endpoints:

        -  Infection rate

        -  primary patency

        -  primary assisted patency

        -  secondary patency

      Secondary endpoints:

        -  complication rate

        -  occurence of bypass stenosis

        -  time needed for preparation of the bypass vein

        -  technical success i. e. successful implatation of the ProVena Graft
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>June 2005</start_date>
  <completion_date type="Anticipated">December 2008</completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>infection rate</measure>
  </primary_outcome>
  <primary_outcome>
    <measure>primary patency</measure>
  </primary_outcome>
  <primary_outcome>
    <measure>primary assisted patency</measure>
  </primary_outcome>
  <primary_outcome>
    <measure>secondary patency</measure>
  </primary_outcome>
  <secondary_outcome>
    <measure>occurrence of complications</measure>
  </secondary_outcome>
  <secondary_outcome>
    <measure>occurence of stenoses</measure>
  </secondary_outcome>
  <secondary_outcome>
    <measure>time needed for preparation of the bypass vein</measure>
  </secondary_outcome>
  <secondary_outcome>
    <measure>technical success</measure>
  </secondary_outcome>
  <enrollment type="Anticipated">50</enrollment>
  <condition>Peripheral Arterial Disease</condition>
  <condition>Peripheral Bypass Surgery</condition>
  <condition>Bypass From Autologous Varicose Vein</condition>
  <condition>External Graft Support</condition>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Implantation of the ProVena vein graft during bypass surgery</intervention_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  aged &gt; 18 years 18 Jahre.

          -  informed consent has been given and patients is complient to protocol

          -  patient needs femoro-distal bypass surgery

          -  only varicose ektatic veins are available

          -  Bypass diameter &gt; 5mm proximal and &gt; 4mm distal.

        Exclusion Criteria:

          -  aged &lt; 18 years

          -  patient unable to take part in the follow-up

          -  known sensibility to polyester

          -  patient not expected to survive the next 12 months due to significant comorbidities

          -  HIV-infection

          -  Patient suffering from a floriding infection at the time of inclusion

          -  infection or colonisation with MRSA

          -  pregnancy

          -  use of immunosuppresive drugs
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Thomas Schmitz-Rixen, MD, Professor</last_name>
    <role>Principal Investigator</role>
    <affiliation>Johann Wolfgang Goethe University Hospital</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Thomas Schmitz-Rixen, MD, PhD</last_name>
    <phone>+496963015349</phone>
    <email>schmitz-rixen@em.uni-frankfurt.de</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Matthias Tenholt, MD</last_name>
    <phone>+496963015349</phone>
    <email>Matthias.Tenholt@kgu.de</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Charité</name>
      <address>
        <city>Berlin</city>
        <zip>10117</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Antje Kasper, MD</last_name>
      <phone>+4930450622213</phone>
      <email>antje.kasper@charite.de</email>
    </contact>
    <investigator>
      <last_name>Antje Kasper, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Cologne University Hospital</name>
      <address>
        <city>Cologne</city>
        <zip>50924</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jan Brunkwall, MD, Professor</last_name>
      <phone>+492214780</phone>
      <email>jan.brunkwall@uk-koeln.de</email>
    </contact>
    <contact_backup>
      <last_name>Viktor Reichert, MD</last_name>
      <phone>+492214780</phone>
      <email>Viktor.Reichert@uk-koeln.de</email>
    </contact_backup>
    <investigator>
      <last_name>Jan Brunkwall, MD, Professor</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Kath. Kliniken Essen-Nord</name>
      <address>
        <city>Essen</city>
        <zip>45329</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Georg Omlor, MD, Professor</last_name>
      <phone>+4920164001751</phone>
      <email>allvisz@kken.de</email>
    </contact>
    <contact_backup>
      <last_name>Thomas Witte, MD</last_name>
      <phone>+4920164001751</phone>
      <email>allvisz@kken.de</email>
    </contact_backup>
    <investigator>
      <last_name>Georg Omlor, MD, Professor</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Frankfurt University Hospital</name>
      <address>
        <city>Frankfurt/Main</city>
        <zip>60590</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Thomas Schmitz-Rixen, MD, Professor</last_name>
      <phone>+496963015349</phone>
      <email>schmitz-rixen@em.uni-frankfurt.de</email>
    </contact>
    <investigator>
      <last_name>Thomas Schmitz-Rixen, MD, Professor</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Nordwestkrankenhaus Frankfurt</name>
      <address>
        <city>Frankfurt</city>
        <zip>60488</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Max Zegelman, MD, Professor</last_name>
      <phone>+496976013235</phone>
      <email>zegelman@t-online.de</email>
    </contact>
    <contact_backup>
      <last_name>Gisela Günther</last_name>
      <phone>+496976014128</phone>
      <email>guenther.gisela@khnw.de</email>
    </contact_backup>
    <investigator>
      <last_name>Max Zegelman, MD, Professor</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Municipal Hospital Karlsruhe</name>
      <address>
        <city>Karlsruhe</city>
        <zip>76133</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Martin Storck, MD, Professor</last_name>
      <phone>+497219742301</phone>
      <email>Martin.Storck@Klinikum-Karlsruhe.com</email>
    </contact>
    <investigator>
      <last_name>Martin Storck, MD, Professor</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Frankenwaldklinik Kronach gGmbH</name>
      <address>
        <city>Kronach</city>
        <zip>96317</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Ralf Peretzke, MD</last_name>
      <phone>+499261597460</phone>
      <email>ralf.peretzke@frankenwaldklinik.de</email>
    </contact>
    <contact_backup>
      <last_name>Gerald Hahn, MD</last_name>
      <phone>+499261597460</phone>
      <email>gerald.hahn@frankenwaldklinik.de</email>
    </contact_backup>
    <investigator>
      <last_name>Gerald Hahn, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Mainz University Hospital</name>
      <address>
        <city>Mainz</city>
        <zip>55101</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Walther Schmiedt, MD, Professor</last_name>
      <phone>+496131177079</phone>
      <email>schmiedt@mail.uni-mainz.de</email>
    </contact>
    <contact_backup>
      <last_name>Achim Neufang, MD</last_name>
      <phone>+496131177079</phone>
      <email>neufang@mail.uni-mainz.de</email>
    </contact_backup>
    <investigator>
      <last_name>Achim Neufang, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Municipal Hospital</name>
      <address>
        <city>Muehldorf</city>
        <zip>84453</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Caspar Thierfelder, MD</last_name>
      <phone>+4986316130</phone>
      <email>caspar.thierfelder@kh-muehldorf.de</email>
    </contact>
    <investigator>
      <last_name>Caspar Thierfelder, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>St. Franziskus Hospital</name>
      <address>
        <city>Muenster</city>
        <zip>48145</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Joerg Tessarek, MD</last_name>
      <phone>+492519353933</phone>
      <email>Joerg.Tessarek@SFH-MUENSTER.de</email>
    </contact>
    <investigator>
      <last_name>Joerg Tessarek, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Verbundkrankenhaus Bernkastel/Wittlich</name>
      <address>
        <city>Wittlich</city>
        <zip>54516</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Paul Walther, MD, Professor</last_name>
      <phone>+496571151161</phone>
      <email>gefaesschirurgie@verbund-krankenhaus.de</email>
    </contact>
    <investigator>
      <last_name>Paul Walther, MD, Professor</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Germany</country>
  </location_countries>
  <reference>
    <citation>Klinkert P, Post PN, Breslau PJ, van Bockel JH. Saphenous vein versus PTFE for above-knee femoropopliteal bypass. A review of the literature. Eur J Vasc Endovasc Surg. 2004 Apr;27(4):357-62. Review.</citation>
    <PMID>15015183</PMID>
  </reference>
  <reference>
    <citation>Moritz A, Grabenwöger F, Raderer F, Ptakovsky H, Magometschnigg H, Ullrich R, Staudacher M. Use of varicose veins as arterial bypass grafts. Cardiovasc Surg. 1993 Oct;1(5):508-12.</citation>
    <PMID>8076087</PMID>
  </reference>
  <reference>
    <citation>Moritz A, Grabenwöger F, Raderer F, Ptakovsky H, Staudacher M, Magometschnigg H, Ullrich R, Wolner E. Mesh tube--constricted varicose veins used as bypass grafts for infrainguinal arterial reconstruction. Arch Surg. 1992 Apr;127(4):416-20.</citation>
    <PMID>1558494</PMID>
  </reference>
  <reference>
    <citation>Neufang A, Dorweiler B, Espinola-Klein C, Reinstadler J, Kirsch D, Schmiedt W, Oelert H. External reinforcement of varicose veins with PTFE prosthesis in infrainguinal bypass surgery -- clinical results. Thorac Cardiovasc Surg. 2003 Apr;51(2):62-6.</citation>
    <PMID>12730812</PMID>
  </reference>
  <verification_date>October 2007</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>April 12, 2007</study_first_submitted>
  <study_first_submitted_qc>April 12, 2007</study_first_submitted_qc>
  <study_first_posted type="Estimate">April 13, 2007</study_first_posted>
  <last_update_submitted>October 2, 2007</last_update_submitted>
  <last_update_submitted_qc>October 2, 2007</last_update_submitted_qc>
  <last_update_posted type="Estimate">October 3, 2007</last_update_posted>
  <keyword>PAD</keyword>
  <keyword>vein bypass</keyword>
  <keyword>supported varicose veins</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Peripheral Arterial Disease</mesh_term>
    <mesh_term>Peripheral Vascular Diseases</mesh_term>
    <mesh_term>Varicose Veins</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

